Poor reliability between Cochrane reviewers and blinded external reviewers when applying the Cochrane risk of bias tool in physical therapy trials
- PMID: 24824199
- PMCID: PMC4019638
- DOI: 10.1371/journal.pone.0096920
Poor reliability between Cochrane reviewers and blinded external reviewers when applying the Cochrane risk of bias tool in physical therapy trials
Abstract
Objectives: To test the inter-rater reliability of the RoB tool applied to Physical Therapy (PT) trials by comparing ratings from Cochrane review authors with those of blinded external reviewers.
Methods: Randomized controlled trials (RCTs) in PT were identified by searching the Cochrane Database of Systematic Reviews for meta-analysis of PT interventions. RoB assessments were conducted independently by 2 reviewers blinded to the RoB ratings reported in the Cochrane reviews. Data on RoB assessments from Cochrane reviews and other characteristics of reviews and trials were extracted. Consensus assessments between the two reviewers were then compared with the RoB ratings from the Cochrane reviews. Agreement between Cochrane and blinded external reviewers was assessed using weighted kappa (κ).
Results: In total, 109 trials included in 17 Cochrane reviews were assessed. Inter-rater reliability on the overall RoB assessment between Cochrane review authors and blinded external reviewers was poor (κ = 0.02, 95%CI: -0.06, 0.06]). Inter-rater reliability on individual domains of the RoB tool was poor (median κ = 0.19), ranging from κ = -0.04 ("Other bias") to κ = 0.62 ("Sequence generation"). There was also no agreement (κ = -0.29, 95%CI: -0.81, 0.35]) in the overall RoB assessment at the meta-analysis level.
Conclusions: Risk of bias assessments of RCTs using the RoB tool are not consistent across different research groups. Poor agreement was not only demonstrated at the trial level but also at the meta-analysis level. Results have implications for decision making since different recommendations can be reached depending on the group analyzing the evidence. Improved guidelines to consistently apply the RoB tool and revisions to the tool for different health areas are needed.
Conflict of interest statement
Figures
Similar articles
-
Validity and Inter-Rater Reliability Testing of Quality Assessment Instruments [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2012 Mar. Report No.: 12-EHC039-EF. Rockville (MD): Agency for Healthcare Research and Quality (US); 2012 Mar. Report No.: 12-EHC039-EF. PMID: 22536612 Free Books & Documents. Review.
-
Testing the risk of bias tool showed low reliability between individual reviewers and across consensus assessments of reviewer pairs.J Clin Epidemiol. 2013 Sep;66(9):973-81. doi: 10.1016/j.jclinepi.2012.07.005. Epub 2012 Sep 13. J Clin Epidemiol. 2013. PMID: 22981249
-
Comparing machine and human reviewers to evaluate the risk of bias in randomized controlled trials.Res Synth Methods. 2020 May;11(3):484-493. doi: 10.1002/jrsm.1398. Epub 2020 Mar 3. Res Synth Methods. 2020. PMID: 32065732
-
Inter-review agreement of risk-of-bias judgments varied in Cochrane reviews.J Clin Epidemiol. 2020 Apr;120:25-32. doi: 10.1016/j.jclinepi.2019.12.016. Epub 2019 Dec 19. J Clin Epidemiol. 2020. PMID: 31866473
-
Assessor burden, inter-rater agreement and user experience of the RoB-SPEO tool for assessing risk of bias in studies estimating prevalence of exposure to occupational risk factors: An analysis from the WHO/ILO Joint Estimates of the Work-related Burden of Disease and Injury.Environ Int. 2022 Jan;158:107005. doi: 10.1016/j.envint.2021.107005. Epub 2021 Nov 30. Environ Int. 2022. PMID: 34991265 Free PMC article.
Cited by
-
Disagreements in risk of bias assessment for randomised controlled trials included in more than one Cochrane systematic reviews: a research on research study using cross-sectional design.BMJ Open. 2019 Apr 1;9(4):e028382. doi: 10.1136/bmjopen-2018-028382. BMJ Open. 2019. PMID: 30940766 Free PMC article.
-
Usability and sensitivity of the risk of bias assessment tool for randomized controlled trials of pharmacist interventions.Int J Clin Pharm. 2019 Jun;41(3):785-792. doi: 10.1007/s11096-019-00818-2. Epub 2019 Apr 9. Int J Clin Pharm. 2019. PMID: 30963446
-
Influence of blinding on treatment effect size estimate in randomized controlled trials of oral health interventions.BMC Med Res Methodol. 2018 May 18;18(1):42. doi: 10.1186/s12874-018-0491-0. BMC Med Res Methodol. 2018. PMID: 29776394 Free PMC article.
-
Perspective: NutriGrade: A Scoring System to Assess and Judge the Meta-Evidence of Randomized Controlled Trials and Cohort Studies in Nutrition Research.Adv Nutr. 2016 Nov 15;7(6):994-1004. doi: 10.3945/an.116.013052. Print 2016 Nov. Adv Nutr. 2016. PMID: 28140319 Free PMC article.
-
Exercise for rheumatoid arthritis of the hand.Cochrane Database Syst Rev. 2018 Jul 31;7(7):CD003832. doi: 10.1002/14651858.CD003832.pub3. Cochrane Database Syst Rev. 2018. PMID: 30063798 Free PMC article.
References
-
- Armijo-Olivo S, Macedo LG, Gadotti IC, Fuentes J, Stanton T, et al. (2008) Scales to Assess the Quality of Randomized Controlled Trials: A Systematic Review. Physical Therapy 88: 156–175. - PubMed
-
- Moher D, Jadad AR, Nichol G, Penman M, Tugwell P, et al. (1995) Assessing the quality of randomized controlled trials: an annotated bibliography of scales and checklists. Controlled Clinical Trials 16: 62–73. - PubMed
-
- Higgins J, Altman DG (2008) Chapter 8: Assessing risk of bias in included studies. In: Higgins J, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 500 [updated February 2008] version 5.0 ed: Available from www.cochrane-handbook.org, February, 2008.
-
- Schulz KF, Chalmers I, Hayes RJ, Altman DG (1995) Empirical evidence of bias: Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. Journal of the American Medical Association 273: 408–412. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources